Kiyokazu Kawabe Selected Research

Kiyokazu Kawabe Research Topics

Disease

4	Parkinson Disease (Parkinson's Disease) 06/2019 - 01/2011
4	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2012 - 02/2004
3	Disease Progression 01/2013 - 01/2011
2	Parkinsonian Disorders (Parkinsonism) 06/2019 - 12/2004
2	Migraine Disorders (Migraine) 04/2018 - 05/2017
2	Epilepsy (Aura) 03/2017 - 01/2011
2	Multiple Sclerosis 09/2015 - 01/2010
2	Motor Neuron Disease (Primary Lateral Sclerosis) 01/2010 - 02/2004
1	Essential Tremor (Essential Tremors) 06/2019
1	Dyskinesias (Dyskinesia) 01/2018
1	Headache (Headaches) 05/2017
1	Dyslipidemias (Dyslipidemia) 03/2017
1	Cerebral Infarction 03/2017
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 03/2017
1	Inflammation (Inflammations) 09/2015
1	Ataxia (Dyssynergia) 06/2015
1	Alzheimer Disease (Alzheimer's Disease) 01/2014
1	Dystonia (Limb Dystonia) 01/2014
1	Torticollis (Wryneck) 01/2014
1	Ophthalmoplegia (External Ophthalmoplegia) 01/2013
1	Encephalitis (Encephalitis, Rasmussen) 01/2013
1	Paraplegia (Spastic Paraplegia) 01/2013
1	Clinical Deterioration 01/2012
1	Liver Abscess 01/2012
1	Sepsis (Septicemia) 01/2012
1	Human Influenza (Influenza) 01/2011
1	Brain Diseases (Brain Disorder) 01/2011
1	Encephalomyelitis (Myeloencephalitis) 01/2011
1	Dysuria 01/2011
1	Paresthesia (Dysesthesia) 01/2011
1	Broca Aphasia (Expressive Aphasia) 01/2011
1	Abnormal Reflex (Hyperreflexia) 01/2011
1	Neuromyelitis Optica (Devic's Disease) 01/2011
1	Measles 11/2010
1	Essential Hypertension 05/2010
1	Hypertension (High Blood Pressure) 05/2010
1	Leukocytosis (Pleocytosis) 01/2010
1	Atrophy 01/2010
1	Muscle Weakness 01/2010
1	Myoclonus (Nocturnal Myoclonus) 01/2010
1	CADASIL 01/2008
1	Dysferlinopathy 07/2003
1	Miyoshi myopathy 07/2003

Drug/Important Bio-Agent (IBA)

4	AntibodiesIBA 01/2013 - 01/2010
3	lomerizineIBA 04/2018 - 01/2011
3	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 04/2018 - 01/2011
3	LipidsIBA 03/2017 - 01/2011
2	Dopamine Plasma Membrane Transport Proteins (Dopamine Transporter)IBA 06/2019 - 01/2018
2	Dopamine Agonists (Dopamine Agonist)IBA 01/2018 - 01/2016
2	Angiotensin Receptor AntagonistsIBA 05/2017 - 05/2010
2	Uric Acid (Urate)IBA 01/2012 - 01/2011
2	Ferritins (Ferritin)IBA 01/2012 - 01/2011
2	Prednisolone (Predate)FDA LinkGeneric 01/2011 - 01/2011
2	Methylprednisolone FDA LinkGeneric 01/2011 - 01/2011
2	Immunoglobulin G (IgG)IBA 01/2011 - 11/2010
2	Proteins (Proteins, Gene)FDA Link 01/2010 - 07/2003
1	Pharmaceutical PreparationsIBA 06/2019
1	Zonisamide (Zonegran)FDA LinkGeneric 01/2018
1	entacapone (Comtan)FDA Link 01/2018
1	Selegiline (E250)FDA LinkGeneric 01/2018
1	Tryptamines (Triptans)IBA 05/2017
1	Analgesics (Analgesic Drugs)IBA 05/2017
1	Telmisartan (Micardis)FDA Link 05/2017
1	Anticonvulsants (Antiepileptic Drugs)IBA 03/2017
1	rotigotine FDA Link 01/2016
1	Substance PIBA 09/2015
1	Interleukin-12 (IL 12)IBA 09/2015
1	CytokinesIBA 09/2015
1	NeuropeptidesIBA 09/2015
1	Explosive Agents (Explosives)IBA 06/2015
1	Donepezil (Aricept)FDA LinkGeneric 01/2014
1	Cholinesterase Inhibitors (Anticholinesterases)IBA 01/2014
1	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 01/2013
1	IronIBA 01/2012
1	oxidized low density lipoproteinIBA 01/2012
1	CreatinineIBA 01/2012
1	Aryldialkylphosphatase (Paraoxonase)IBA 01/2011
1	Aquaporin 4IBA 01/2011
1	Immunoglobulin M (IgM)IBA 01/2011
1	SteroidsIBA 01/2011
1	GadoliniumIBA 01/2011
1	Zanamivir (Relenza)FDA Link 01/2011
1	olmesartanIBA 05/2010
1	Serine (L-Serine)FDA Link 01/2010
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 01/2010
1	Codon (Codons)IBA 01/2010
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2010
1	Interleukin-6 (Interleukin 6)IBA 01/2010
1	Superoxide Dismutase-1IBA 01/2010
1	Cysteine (L-Cysteine)FDA Link 01/2008
1	Epidermal Growth Factor (EGF)IBA 01/2008
1	BilirubinIBA 02/2005
1	VitaminsIBA 12/2004
1	Choline O-Acetyltransferase (Choline Acetyltransferase)IBA 02/2004
1	T 588IBA 02/2004

Therapy/Procedure

2	Therapeutics 01/2011 - 01/2011
1	Transdermal Patch 01/2016
1	Denervation 01/2013
1	Total Parenteral Nutrition 01/2012
1	Oral Administration 01/2011